These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32986828)

  • 1. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
    Albain KS; Gray RJ; Makower DF; Faghih A; Hayes DF; Geyer CE; Dees EC; Goetz MP; Olson JA; Lively T; Badve SS; Saphner TJ; Wagner LI; Whelan TJ; Ellis MJ; Wood WC; Keane MM; Gomez HL; Reddy PS; Goggins TF; Mayer IA; Brufsky AM; Toppmeyer DL; Kaklamani VG; Berenberg JL; Abrams J; Sledge GW; Sparano JA
    J Natl Cancer Inst; 2021 Apr; 113(4):390-399. PubMed ID: 32986828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial.
    Kantor O; King TA; Freedman RA; Mayer EL; Chavez-MacGregor M; Korde LA; Sparano JA; Mittendorf EA
    JAMA Surg; 2023 Jun; 158(6):583-591. PubMed ID: 37043210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Recurrence and Mortality in a Multi-Ethnic Breast Cancer Population.
    Kabat GC; Ginsberg M; Sparano JA; Rohan TE
    J Racial Ethn Health Disparities; 2017 Dec; 4(6):1181-1188. PubMed ID: 28004356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features.
    Benefield HC; Reeder-Hayes KE; Nichols HB; Calhoun BC; Love MI; Kirk EL; Geradts J; Hoadley KA; Cole SR; Earp HS; Olshan AF; Carey LA; Perou CM; Troester MA
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
    Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D
    Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residential racial segregation and mortality among black, white, and Hispanic urban breast cancer patients in Texas, 1995 to 2009.
    Pruitt SL; Lee SJ; Tiro JA; Xuan L; Ruiz JM; Inrig S
    Cancer; 2015 Jun; 121(11):1845-55. PubMed ID: 25678448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
    Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
    JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
    Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
    J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
    Elledge RM; Clark GM; Chamness GC; Osborne CK
    J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer.
    Martinez SR; Beal SH; Chen SL; Canter RJ; Khatri VP; Chen A; Bold RJ
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):787-92. PubMed ID: 20619550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
    Freedman RA; Virgo KS; He Y; Pavluck AL; Winer EP; Ward EM; Keating NL
    Cancer; 2011 Jan; 117(1):180-9. PubMed ID: 20939011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y; West R; Weber JD; Colditz GA
    Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer.
    Pastoriza JM; Karagiannis GS; Lin J; Lanjewar S; Entenberg D; Condeelis JS; Sparano JA; Xue X; Rohan TE; Oktay MH
    Clin Exp Metastasis; 2018 Oct; 35(7):613-623. PubMed ID: 30136072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
    Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV
    J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situ.
    Dania V; Liu Y; Ademuyiwa F; Weber JD; Colditz GA
    Breast Cancer Res; 2019 Nov; 21(1):120. PubMed ID: 31727116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes.
    Chavez-Macgregor M; Liu S; De Melo-Gagliato D; Chen H; Do KA; Pusztai L; Fraser Symmans W; Nair L; Hortobagyi GN; Mills GB; Meric-Bernstam F; Gonzalez-Angulo AM
    Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):316-23. PubMed ID: 24296856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in tumor stage and survival for colorectal cancer in an insured population.
    Doubeni CA; Field TS; Buist DS; Korner EJ; Bigelow C; Lamerato L; Herrinton L; Quinn VP; Hart G; Hornbrook MC; Gurwitz JH; Wagner EH
    Cancer; 2007 Feb; 109(3):612-20. PubMed ID: 17186529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
    Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
    JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race and ethnicity and breast cancer outcomes in an underinsured population.
    Komenaka IK; Martinez ME; Pennington RE; Hsu CH; Clare SE; Thompson PA; Murphy C; Zork NM; Goulet RJ
    J Natl Cancer Inst; 2010 Aug; 102(15):1178-87. PubMed ID: 20574040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.